A crucial step for the selection
of proper amorphous solid dispersion
(ASD) matrix carriers is the in-depth assessment of drug/polymer physicochemical
properties. In this context, the present study extends the work of
previously published attempts by evaluating the formation of simvastatin
(SIM)–poly(vinylpyrrolidone) (PVP) ASDs with the aid of thermodynamic
and molecular modeling. Specifically, the implementation of both Flory–Huggins
lattice theory and molecular dynamics (MD) simulations was able to
predict the miscibility between the two components (a finding that
was experimentally verified via differential scanning calorimetry
(DSC) and hot stage polarized microscopy), while a complete temperature-concentration
phase-transition profile was constructed, leading to the identification
of the thermodynamically metastable and unstable ASD zones. Furthermore,
as in the case of previously published reports, the analysis of the
ASDs via Fourier transform infrared spectroscopy did not clarify the
type and extent of observed molecular interactions. Hence, in the
present study, a computer-based MD simulation model was developed
for the first time in order to gain an insight into the properties
of the observed interactions. MD amorphous assemblies of SIM, PVP,
and their mixtures were initially developed, and the calculated glass
transition temperatures were in close agreement with experimentally
obtained results, indicating that the developed models could be considered
as realistic representations of the actual systems. Furthermore, molecular
interactions evaluation via radial distribution function and radius
of gyration analysis revealed that increasing SIM content results
in a significant PVP chain shrinkage, which eventually leads to SIM–SIM
amorphous intermolecular interactions, leading to the formation of
amorphous drug zones. Finally, MD-based results were experimentally
verified via DSC.